BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24189245)

  • 1. Penetration of GSK1322322 into epithelial lining fluid and alveolar macrophages as determined by bronchoalveolar lavage.
    Naderer OJ; Rodvold KA; Jones LS; Zhu JZ; Bowen CL; Chen L; Dumont E
    Antimicrob Agents Chemother; 2014; 58(1):419-23. PubMed ID: 24189245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Plasma and Intrapulmonary Concentrations of Nafithromycin (WCK 4873) in Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Chugh R; Gupta M; Friedland HD; Bhatia A
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, tolerability and pharmacokinetics of repeat dosing of the antibiotic GSK1322322, a peptide deformylase inhibitor: a randomized placebo-controlled study.
    Naderer OJ; Dumont E; Zhu J; Kurtinecz M; Jones LS
    J Antimicrob Chemother; 2013 Aug; 68(8):1901-9. PubMed ID: 23557930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapulmonary Pharmacokinetics of Levonadifloxacin following Oral Administration of Alalevonadifloxacin to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Chugh R; Gupta M; Yeole R; Patel A; Bhatia A
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose safety, tolerability, and pharmacokinetics of the antibiotic GSK1322322, a novel peptide deformylase inhibitor.
    Naderer OJ; Dumont E; Zhu J; Kurtinecz M; Jones LS
    Antimicrob Agents Chemother; 2013 May; 57(5):2005-9. PubMed ID: 23403431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, tolerability, and pharmacokinetics of oral and intravenous administration of GSK1322322, a peptide deformylase inhibitor.
    Naderer OJ; Jones LS; Zhu J; Kurtinecz M; Dumont E
    J Clin Pharmacol; 2013 Nov; 53(11):1168-76. PubMed ID: 23907665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects.
    Wenzler E; Gotfried MH; Loutit JS; Durso S; Griffith DC; Dudley MN; Rodvold KA
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7232-9. PubMed ID: 26349830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Isaacs RD; O'Donnell JP; Stone E
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Gupta V; Ek A; Srivastava P; Talley A; Bruss J
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0059022. PubMed ID: 35762796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects.
    Gotfried MH; Horn K; Garrity-Ryan L; Villano S; Tzanis E; Chitra S; Manley A; Tanaka SK; Rodvold KA
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and Penetration of Sitafloxacin into Alveolar Epithelial Lining Fluid in Critically Ill Thai Patients with Pneumonia.
    Paiboonvong T; Nosoongnoen W; Sathirakul K; Tangsujaritvijit V; Kaemapairoj J; Tragulpiankit P; Montakantikul P
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapulmonary pharmacokinetics of S-013420, a novel bicyclolide antibacterial, in healthy Japanese subjects.
    Furuie H; Saisho Y; Yoshikawa T; Shimada J
    Antimicrob Agents Chemother; 2010 Feb; 54(2):866-70. PubMed ID: 19933801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, tolerability, and efficacy of GSK1322322 in the treatment of acute bacterial skin and skin structure infections.
    Corey R; Naderer OJ; O'Riordan WD; Dumont E; Jones LS; Kurtinecz M; Zhu JZ
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6518-27. PubMed ID: 25136015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of SPR206 in Plasma, Pulmonary Epithelial Lining Fluid, and Alveolar Macrophages following Intravenous Administration to Healthy Adult Subjects.
    Rodvold KA; Bader J; Bruss JB; Hamed K
    Antimicrob Agents Chemother; 2023 Jul; 67(7):e0042623. PubMed ID: 37338378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers.
    Housman ST; Pope JS; Russomanno J; Salerno E; Shore E; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2012 May; 56(5):2627-34. PubMed ID: 22330925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing Antibacterial Development Risk for GSK1322322 by Exploring Potential Human Dose Regimens in Nonclinical Efficacy Studies Using Immunocompetent Rats.
    Hoover JL; Singley CM; Elefante P; DeMarsh P; Zalacain M; Rittenhouse S
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection.
    Hoover J; Lewandowski T; Straub RJ; Novick SJ; DeMarsh P; Aubart K; Rittenhouse S; Zalacain M
    Antimicrob Agents Chemother; 2016 Jan; 60(1):180-9. PubMed ID: 26482300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapulmonary concentrations of telithromycin: clinical implications for respiratory tract infections due to Streptococcus pneumoniae.
    Ong CT; Dandekar PK; Sutherland C; Nightingale CH; Nicolau DP
    Chemotherapy; 2005 Oct; 51(6):339-46. PubMed ID: 16224186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapulmonary Pharmacokinetics of Lascufloxacin in Healthy Adult Volunteers.
    Furuie H; Tanioka S; Shimizu K; Manita S; Nishimura M; Yoshida H
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and Intrapulmonary Concentrations of Cefepime and Zidebactam following Intravenous Administration of WCK 5222 to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Chugh R; Gupta M; Patel A; Chavan R; Yeole R; Friedland HD; Bhatia A
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.